Phenotypic and transcriptomic characterization of bicalutamide and enzalutamide resistance in castration-resistant prostate cancer cells
Reetta Nätkin, Milja I. Paloneva, Paavo V. H. Raittinen, Heimo Syvälä, Merja Bläuer, Teuvo L.J. Tammela, Pauliina Ilmonen, Matti Nykter, Aino Siltari, Teemu Johannes Murtola
This study characterizes transcriptomic and phenotypic changes in prostate cancer cells developing resistance to bicalutamide and enzalutamide, showing treatment sequence affects drug resistance and docetaxel sensitivity.
bioRxiv · May 30, 2025 · PreprintCancer Biology